Pediatric Hematology/

Welcome to Pediatric Cancer Biology

The overall research goals of the program are to elucidate the molecular pathogenesis of pediatric cancers and to translate this knowledge into improved treatments. This long-term objective has three major components.

The first is to identify the molecular aberrations that induce and sustain the aberrant growth of pediatric cancers.

The second is to elucidate the molecular mechanisms by which these aberrations disrupt normal growth control processes.

The third is to design therapies that specifically target these molecular abnormalities for treatment of children with cancer and to devise new molecular tools for monitoring the response to therapy in real time.

Michael Cleary, MD
Professor and Section Chief
Pediatric Cancer Biology

Section Chief
Mike Cleary, MD

Michael Cleary, MD is currently a Professor in Pathology and the section Chief of the Pediatric Cancer Biology Program. His research interests focus on the molecular pathogenesis of acute leukemias. His laboratory group has discovered several of the major cancer genes that are mutated in childhood leukemias.

Make a Gift

Stanford Medicine Resources:

Footer Links: